Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.205 USD | +1.26% | -1.24% | -12.13% |
Mar. 21 | North American Morning Briefing : Investors -2- | DJ |
Mar. 14 | AVROBIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.13% | 53.38M | |
-3.12% | 102B | |
+1.63% | 96.29B | |
+2.13% | 22.18B | |
-15.45% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-15.70% | 16.36B | |
+5.33% | 13.97B | |
+32.45% | 12.17B |
- Stock Market
- Equities
- AVRO Stock
- News AVROBIO, Inc.
- Avrobio : Says FDA Approval of Sanofi's Fabrazyme Leaves Head-to-Head Trial as Best Path for Its Fabry Disease Treatment; Stock Sinks